News Focus
News Focus
icon url

DewDiligence

03/16/11 11:36 PM

#116571 RE: tinkershaw #116568

Correct—the trial was testing Symlin (pramlintide) + metreleptin (not Symlin monotherapy).
icon url

DewDiligence

08/04/11 10:54 PM

#124534 RE: tinkershaw #116568

AMLN/Takeda officially dump Symlin + Metreleptin obesity program:

http://finance.yahoo.com/news/Amylin-and-Takeda-Discontinue-prnews-2389602892.html?x=0&.v=1

Not surprising given the safety problem encountered five months ago (#msg-60998172).